http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#Head http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#assertion http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#provenance http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#pubinfo http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#assertion http://purl.obolibrary.org/obo/DOID_1558 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1558 http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01197 http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association http://www.w3.org/2000/01/rdf-schema#label "Captopril tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin-converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor). Do not co-administer aliskiren with captopril tablets in patients with diabetes (see PRECAUTIONS, Drug Interactions Captopril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer captopril tablet within 36 hours of switching to or from sacubitril/valsartan, a nepriltsin inhibitor ( see PRECAUTIONS, Drug Interactions" http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01197 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#provenance http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#pubinfo http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig http://purl.org/nanopub/x/hasSignature ImzXa5p4U8QDmtSTLSd1JNHNUPKD+gzbiqX3vH5URvU3okd8s5ksrDAqKBQbwbGIHLy/cJWjhDGAogc7GUtcJH2S48Eq3r/+A0UOSZhmvz/gr6NCK6XUjBwj9mMCgah/V3EIJ0/1btTBp6/qbVmjKDK48KPhrSxKgEfpQXK5J4w= http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk http://purl.org/dc/terms/created 2021-08-23T13:05:55.070+02:00 http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAdgjzURUfY36lk34WS-ToOxuSA4VhDe_QAirFVFhZjFk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY